• Will acquire vaccine business
• Will carry a wide variety of products, vaccine to therapeutic drugs
• Grow sales of SYCREST, antipsychotic drug
• Will enhance antipsychotic drug product line when launch Ziprasidone
• Grow sales using fusion strategy*
• Create sales structure optimal for growing sales of antipsychotic drugs
* Propose optimal drug from extensive product line based on medical symptoms
• BILANOA, the key product
• Sales of BILANOA jumped during the FYE March 2018 hay-fever season, contribute to good performance
• Increase market share to 10% and higher through intensive marketing activities
Increase presence in each business
Drugs for infectious diseases
• Will acquire vaccine business
• Will carry a wide variety of products, vaccine to therapeutic drugs
Antidepressant drugs and antipsychotic drugs• Grow sales of SYCREST, antipsychotic drug
• Will enhance antipsychotic drug product line when launch Ziprasidone
• Grow sales using fusion strategy*
• Create sales structure optimal for growing sales of antipsychotic drugs
* Propose optimal drug from extensive product line based on medical symptoms
Immune system and inflammatory disorders• BILANOA, the key product
• Sales of BILANOA jumped during the FYE March 2018 hay-fever season, contribute to good performance
• Increase market share to 10% and higher through intensive marketing activities